ストックスクリーナーアプリを入手
13.31
1.63%
-0.18
アフターアワーズ：
13.31
前日終値:
$13.49
開ける：
$13.47
24時間の取引高:
234.96K
Relative Volume:
1.91
時価総額：
$583.66M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-0.60%
1か月 パフォーマンス:
-21.11%
6か月 パフォーマンス:
+25.54%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$12.91
$13.54
1週間の範囲:
$12.81
$14.02
52週間の値動き範囲:
$6.71
$18.67
Maze Therapeutics Inc Stock (MAZE) Company Profile
名前
Maze Therapeutics Inc
セクター
電話
(650) 850-5070
住所
171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO
MAZE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MAZE
Maze Therapeutics Inc
|
13.31 | 584.69M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Maze Therapeutics Inc Stock (MAZE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-23 | 開始されました | H.C. Wainwright | Buy |
| 2025-07-08 | 開始されました | Wedbush | Outperform |
Maze Therapeutics Inc (MAZE) 最新ニュース
Maze Therapeutics reports Q2 EPS (77c), consensus ($1.15) - MSN
Analysts Apply Wyckoff Model to Maze Therapeutics Inc. StockTrend Reversal & Accurate Intraday Trading Signals - beatles.ru
Trend Reversal Possible in Maze Therapeutics Inc. Charts Indicate2025 Top Gainers & AI Enhanced Trading Signals - thegnnews.com
Is Maze Therapeutics Inc. a candidate for recovery play2025 Market Outlook & Momentum Based Trading Signals - Newser
Risk adjusted return profile for Maze Therapeutics Inc. analyzedJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser
Using data models to predict Maze Therapeutics Inc. stock movementJuly 2025 Intraday Action & Short-Term Trading Alerts - Newser
Is it time to cut losses on Maze Therapeutics Inc.July 2025 EndofMonth & High Accuracy Swing Entry Alerts - Newser
Using data filters to optimize entry into Maze Therapeutics Inc.Weekly Risk Summary & AI Enhanced Trading Signals - Newser
Can Maze Therapeutics Inc. hit a new high this monthJobs Report & AI Forecast Swing Trade Picks - Newser
Maze Therapeutics Inc. stock chart pattern explained2025 Investor Takeaways & Long-Term Growth Portfolio Plans - Newser
When is the best time to exit Maze Therapeutics Inc.Trade Volume Report & Daily Market Momentum Tracking - Newser
Using fundamentals and technicals on Maze Therapeutics Inc.July 2025 Decliners & Momentum Based Trading Signals - Newser
Using Ichimoku Cloud for Maze Therapeutics Inc. technicalsLong Setup & Accurate Technical Buy Alerts - Newser
Published on: 2025-08-19 02:45:04 - Newser
Should you wait for a breakout in Maze Therapeutics Inc.Quarterly Risk Review & Expert Verified Movement Alerts - Newser
Maze Therapeutics Inc. Included in Top Momentum Scan2025 Dividend Review & High Return Trade Opportunity Guides - kangso.co.kr
Q3 EPS Forecast for Maze Therapeutics Lowered by Analyst - Defense World
Institutional scanner results for Maze Therapeutics Inc.Weekly Profit Summary & Weekly High Conviction Trade Ideas - Newser
Wedbush Increases Earnings Estimates for Maze Therapeutics - Defense World
Price Reversal in Maze Therapeutics Inc. Traders Watch Closely2025 Top Decliners & Stock Timing and Entry Methods - 선데이타임즈
Published on: 2025-08-16 04:08:13 - Newser
What is Maze Therapeutics Inc.’s book value per shareJuly 2025 Levels & Expert Curated Trade Setup Alerts - sundaytimes.kr
What’s the recovery path for long term holders of Maze Therapeutics Inc.Entry Point & Free Community Consensus Stock Picks - Newser
Visual trend scoring systems applied to Maze Therapeutics Inc.Insider Selling & Community Consensus Trade Alerts - Newser
What moving averages say about Maze Therapeutics Inc.Trade Analysis Summary & Real-Time Buy Signal Notifications - Newser
Maze Therapeutics (NASDAQ:MAZE) Rating Increased to Hold at Wall Street Zen - Defense World
HC Wainwright Lifts Earnings Estimates for Maze Therapeutics - Defense World
Will a bounce in Maze Therapeutics Inc. offer an exitBond Market & Fast Gain Swing Trade Alerts - Newser
How Maze Therapeutics Inc. stock performs during market volatility2025 Trading Volume Trends & High Accuracy Trade Signal Alerts - newsyoung.net
Maze Therapeutics: Promising Future with Strong Pipeline and Robust Financial Health - TipRanks
Maze Therapeutics Plunges 17.08% Despite Beating EPS Estimates - AInvest
Why Maze Therapeutics Inc. stock attracts strong analyst attentionPortfolio Risk Report & Real-Time Volume Spike Alerts - Newser
RSI Divergence May Trigger a Bounce in Maze Therapeutics Inc.July 2025 Levels & Expert Curated Trade Setups - newsyoung.net
How to escape a deep drawdown in Maze Therapeutics Inc.Weekly Trading Summary & Advanced Swing Trade Entry Alerts - Newser
Maze Therapeutics, Inc.: Buy Rating Backed by Promising Clinical Developments and Strategic Trials - TipRanks
Maze Therapeutics: Promising Innovations in PKU and CKD Treatment with MZE782 - TipRanks
Maze Therapeutics Inc (MAZE) 財務データ
Maze Therapeutics Inc (MAZE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.34%
0.52%
大文字化:
|
ボリューム (24 時間):